NTIS Publication Number	Study Number	Description
PB93506087	ACTG 002	AIDS Clinical Trials Group 002: Analysis Data Set (for Microcomputers). - Data file.
PB94501871	ACTG 019	Safety and Efficacy of Zidovudine for Asymptomatic HIV Infected Individuals (for Microcomputers). - Data file.
PB95500229	ACTG 021	Controlled Comparative Trial of Trimethoprim-Sulfamethazole (T-SMZ) Versus Aerosolized Pentamidine (AP) for Secondary Prophylaxis of PCP in AIDS Patients Receiving Azidothymidine (AZT) (July 1988-November 1990) (for Microcomputers). - Data file.
PB97501258	ACTG 051	AIDS Clinical Trials Group Study (ACTG 051): A Double-Blind Placebo-Controlled Trial to Evaluate Intravenous Gamma Globulin in Children with Symptomatic HIV Infection Receiving Zidovudine (for Microcomputers). - Data file.
Not Available	ACTG 076	A Phase III Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerance of Zidovudine for the Prevention of Maternal-Fetal HIV Transmission.
PB96502141	ACTG 081	ACTG 081 Publication Data Set (for Microcomputers). - Data file.
Not Available	ACTG 116A	Zidovudine Compared With Didanosine in Patients With Advanced HIV Type 1 Infection and Little or No Previous Experience With Zidovudine"
PB94504099	ACTG 116B/117	Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddl)(Bmy-40900) and Zidovudine Therapy of Patients with HIV Infection Who Have Been on Long Term Zidovudine Treatment (ACTG116B/117) (for Microcomputers). - Data file.
PB99500571	ACTG 128	ACTG 128: A Randomized Blinded Trial to Evaluate the Safety and Tolerance of High Versus Low Dose Zidovudine Administered to Children with Human Immunodeficiency Virus (on Diskette). - Data file.
PB93120574	ACTG 129	Studies of the Ocular Complication of AIDS (SOCA) CMV Retinitis Trial: Foscarnet Ganciclovir Component AIDS Clinical Trial Group (ACTG) Protocol 129. Handbook (Version 2.0). - Clinical trial handbook.
PB2002107313	ACTG 129	Database Documentation for Mortality in Patients with Acquired Immunodeficiency Treated with Either Foscarnet or Ganciclovir for Cytomegalovirus Retinitis: The Foscarnet-Ganciclovir CMV Retinitits Trail (FGCRT). - Final rept.
PB96109731	ACTG 129	Studies of the Ocular Complications of AIDS (SOCA) Foscarnet Ganciclovir CMV Retinitis Trial (FGCRT) Morbidity and Toxicity. AIDS Clinical Trials Group (ACTG) Protocol 129. - Clinical trial handbook.
PB96109756	ACTG 129	Studies of Ocular Complications of AIDS (SOCA). Foscarnet- Ganciclovir Cytomegalovirus Retinitis Trial (FGCRT). AIDS Clinical Trial Group (ACTG) Protocol 129. Antiviral Effects of Foscarnet and Ganciclovir Therapy on HIV p24 Antigen in Patients with AIDS and Cytomegalovirus. - Clinical trial handbook.
PB2004500001	ACTG 142	Phase 3 Randomized Trial of Low Dose Versus Standard Dose m-BACOD Chemotherapy with rGM-CSF for Treatment of AIDS-Associated Non-Hodgkins Lymphona (ACTG 142). - Data files.
PB2004100661	ACTG 142	Phase 3 Randomized Trial of Low Dose Versus Standard Dose m-BACOD Chemotherapy with rGM-CSF for Treatment of AIDS-Associated Non-Hodgkins Lymphona (ACTG 142) Documentation. - Final rept.
PB96502695	ACTG 155	Analysis Datasets for ACTG 155 (for Microcomputers). - Data file.
PB98172539	ACTG 175	ACTG 175: Randomized, Double-Blind Phase 2/3 Trial of Monotherapy vs. Combination Therapy with Nucleoside Analogues in HIV-Infected Persons with CD4 Cells >/=200 and </=500/cmm. Final Protocol and List of Changes.
PB99500159	ACTG 175	ACTG 175: A Randomized, Double-Blind, Placebo-Controlled Trial (on Diskette).
PB99500167	ACTG 175	ACTG 175: A Virology Substudy (on Diskette). - Data file.
PB2003500100	ACTG 193A	Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Data Collection Forms (as of 24 September 1999).
PB2006500029	ACTG 193A	"A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS"
PB2006500029	ACTG 196	ACTG 196: Aids Clinical Trials Group (on CD-ROM). The efficacy and safety of clarithromycin, 500 mg BID, rifabutin, 300-450 mg QD, and the combination for prevention of Mycobacterium avium complex (MAC) disease were compared in a randomized, double-blinded, placebo-controlled trial in patients with AIDS.
PB2005500119	ACTG 200	ACTG 200: A Phase III, Randomized Trial of Topical Vaginal Fluorouracil Maintenance Therapy vs. Observation After Standard Treatment for High Grade Cervical Dysplasia in HIV-Infected Women.
PB2004500003	ACTG 204	Randomized, Double-Blind Trial of Valacyclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection (ACTG 204) (on diskette). - Data file.
PB2004100662	ACTG 204	Randomized, Double-Blind Trial of Valacyclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection (ACTG 204) Documentation.
PB2004100662	ACTG 204	"A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection"
PB96109723	ACTG 228	Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Retreatment Trial (CRRT). AIDS Clinical Trial Group (ACTG) protocol 228. - Data collection forms.
PB96109749	ACTG 228	Studies of the Ocular Complications of AIDS (SOCA). CMV Retinitis Retreatment Trial (CRRT) Handbook (Version 1.0). AIDS Clinical Trials Group (ACTG) 228. - Clinical trial handbook.
PB96109715	ACTG 228	Studies of Ocular Complications of AIDS (SOCA). CMV Retinitis Retreatment Trial CRRT, ACTG 228. Protocol, Version 2.2. December 1, 1992. - Clinical trials.
PB99501629	ACTG 240	"A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection"
PB99502114	ACTG 251	ACTG 251: Esophageal Stratum (on Diskette). - Data file.
PB99501645	ACTG 251	ACTG 251: Oral Aphthous Ulcers (on Diskette). - Data file.
PB97170310	ACTG 281	Studies of Ocular Complications of AIDS. HPMPC Peripheral CMV Retinitis Trial, Protocol, Version 1.4.
PB97170328	ACTG 281	SOCA HPMPC Peripheral CMV Retinitis Trial (HPCRT). Manual (Version 1.1).
PB97170195	ACTG 281	Studies of the Ocular Complications of AIDS. HPMPC Peripheral CMV Retinitis Trial (HPCRT). Forms Book.
PB2005500120	ACTG 293	ACTG 293: A Randomized Phase III Trial of Oral Isotretinoin vs. Observation for Low Grade Squamous Intraepithelial Lesions in HIV Infected Women.
PB97170336	ACTG 294	Studies of Ocular Complications of AIDS (SOCA). A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT). Version 2.
PB97170351	ACTG 294	Studies of the Ocular Complications of AIDS (SOCA). Monoclonal Antibody CMV Retinitis Trial (MACRT) Forms and Charts Notebook.
PB97170344	ACTG 294	Studies of the Ocular Complications of AIDS (SOCA). Monoclonal Antibody CMV Retinitis Trial (MACRT) Manual (Version 1.0).
PB2002108495	ACTG 294	Studies of Ocular Complications of AIDS (SOCA). The Monoclonal Cytomegalovirus Retinitis Trial (MARCT) Database Documentation for MSL-109 Adjuvant Therapy for Cytomegalovirus Retinitis in Patients with Acquired Immunodeficiency Syndrome (AIDS) Archives of Ophthalmology 115:1528-1536, 1997.
Not Available	ACTG 320	A Randomized, Double-Blind, Phase III Study of Indinavir Sulfate (IDV) with Open-Label ZDV or Stavudine (d4T) and Lamivudine (3TC) in Subjects with HIV Infection with CD4 Cell Counts <= 200 Cells/mm3 and >= 3 Months of Prior Zidovudine (ZDV).
PB2004500016	ACTG 338	Nucleoside Analogs Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Controlled Trial (ACTG 338) (raw data on CD-ROM).
PB2004500016	ACTG 338	Nucleoside Analogs Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Controlled Trial (ACTG 338) (raw data on CD-ROM).
PB2002107314	ACTG 350	Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Protocol, Version 6.1 (dated 06 Auguest 1999).
PB2002107308	ACTG 350	Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the Database Documentation for Ganciclovir Implant Pus Oral Ganciclovir Versus Parenteral Cidofovir for the Treament of Cytomegalovirus Tetinitis in Patients with Acquired Immunodeficiency Syndrome: The Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT).
PB2002107315	ACTG 350	Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Data Collection Forms (as of 24 September 1999).
PB2002107310	ACTG 350	Studies of the Ocular Complications of AIDS (SOCA) in Collaboration with the AIDS Clinical Trials Group (ACTG) Protocol 350 Ganciclovir Cidofovir CMV Retinitis Trial (GCCRT) Handbook (Version 3 dated 2 September 1999).
PB2005500116	ACTG 384	Study of Protease Inhibitor and/or Non-nucleoside Reverse Transcriptase Inhibitor with Dual Nucleosides in Initial Therapy of HIV Infection (on CD-ROM).
PB2005500118	ACTG 388	A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens Versus a 3-Drug Regimen in Advanced Human Immunodeficiency Virus (on CD-ROM).
PB96502158	ACTG 931	ACTG 981 Publication Data Set (for Microcomputers). - Data file.
PB2005500135	ACTG 5071	5071: A Prospective, Multicenter, PhaseII/III, Open-Label, Controlled Randomized Trial Evaluating Safety, Efficacy and Tolerability of IFN-alfa-2a + Ribavirin Versus PEG-IFN-alfa-2a + Ribavirin for Chronic HCV Infection in Individuals Coinfected with HIV-1.